FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281708744> ?p ?o ?g. }

• W4281708744 endingPage "104018" @default.
• W4281708744 startingPage "104018" @default.
• W4281708744 abstract "Nasopharyngeal cancer is a tumor that occurs in the mucous epithelium of the nasopharynx. Due to its rapid growth and early metastatic nature, the successful treatment of nasopharyngeal cancer is highly challenging. Here, we intended to assess the in vitro anticancer property of brassinin against the nasopharyngeal cancer C666-1 cells. The in vitro free radical scavenging property of the brassinin was assessed by various free radical scavenging activities such as FRAP, DPPH, chemiluminescence (CL), and ORAC assays. The cytotoxic level of the brassinin (1–50 µM) against the nasopharyngeal cancer C666-1 cells and normal Vero cells were assessed by the MTT cytotoxicity assay. The levels of TBARS, GSH, and the SOD activity was assessed using kits. The level of ROS generation, MMP, and apoptosis were investigated by the respective fluorescent staining techniques. The flow cytometry analysis was done to scrutinize the cell cycle arrest. The Bax/Bcl-2 level and caspase activities were examined using respective kits. The brassinin treatment effectively scavenged the free radicals, which are assessed by the FRAP, DPPH, chemiluminescence (CL), and ORAC assays. The proliferation of brassinin treated C666-1 cells were decreased remarkably, while the same concentration of brassinin did not disturbed the Vero cell viability. The 30 µM of brassinin effectively increased the ROS production, depleted the MMP, and stimulated the apoptosis in the C666-1 cells. The brassinin increased the TBARS and depleted the GSH and SOD in the C666-1 cells. The flow cytometry analysis revealed that the brassinin administration improved the G0/G1 ratio and decreased the proportion of cells with ‘S’ and ‘G2/M’ phase. The Bax, caspase-3 and −9 were elevated and Bcl-2 level was decreased in the brassinin administered C666-1 cells. Our findings discovered that the brassinin has the capacity to prevent the proliferation and stimulate the apoptotic cell death C666‐1 cells via blocking cell cycle and increasing oxidative stress and apoptotic markers. Hence, it can be a talented therapeutic agent to treat the nasopharyngeal cancer in the future." @default.
• W4281708744 created "2022-06-13" @default.
• W4281708744 creator A5018298015 @default.
• W4281708744 creator A5035894434 @default.
• W4281708744 creator A5049096571 @default.
• W4281708744 creator A5064794022 @default.
• W4281708744 creator A5089922249 @default.
• W4281708744 date "2022-09-01" @default.
• W4281708744 modified "2023-10-16" @default.
• W4281708744 title "Brassinin inhibits proliferation and induces cell cycle arrest and apoptosis in nasopharyngeal cancer C666-1 cells" @default.
• W4281708744 cites W1507210542 @default.
• W4281708744 cites W1880734817 @default.
• W4281708744 cites W1896508875 @default.
• W4281708744 cites W1964957521 @default.
• W4281708744 cites W1975587857 @default.
• W4281708744 cites W1975735178 @default.
• W4281708744 cites W1985544592 @default.
• W4281708744 cites W1988398656 @default.
• W4281708744 cites W2045094910 @default.
• W4281708744 cites W2047394994 @default.
• W4281708744 cites W2065853716 @default.
• W4281708744 cites W2096306846 @default.
• W4281708744 cites W2102310008 @default.
• W4281708744 cites W2114834447 @default.
• W4281708744 cites W2134878389 @default.
• W4281708744 cites W2141902029 @default.
• W4281708744 cites W2165292984 @default.
• W4281708744 cites W2167807253 @default.
• W4281708744 cites W2170580929 @default.
• W4281708744 cites W2177243765 @default.
• W4281708744 cites W2222937713 @default.
• W4281708744 cites W2345151309 @default.
• W4281708744 cites W2515296714 @default.
• W4281708744 cites W2531225026 @default.
• W4281708744 cites W2548961292 @default.
• W4281708744 cites W2587756991 @default.
• W4281708744 cites W2589060305 @default.
• W4281708744 cites W2613163105 @default.
• W4281708744 cites W2744506250 @default.
• W4281708744 cites W2753835940 @default.
• W4281708744 cites W2771326106 @default.
• W4281708744 cites W2778524473 @default.
• W4281708744 cites W2899403715 @default.
• W4281708744 cites W2910046601 @default.
• W4281708744 cites W2940445524 @default.
• W4281708744 cites W2945182311 @default.
• W4281708744 cites W2949557124 @default.
• W4281708744 cites W2972713173 @default.
• W4281708744 cites W2993190115 @default.
• W4281708744 cites W3005154666 @default.
• W4281708744 cites W3012638502 @default.
• W4281708744 cites W3015759765 @default.
• W4281708744 cites W3048529979 @default.
• W4281708744 cites W3092869243 @default.
• W4281708744 cites W3094712772 @default.
• W4281708744 cites W3117936151 @default.
• W4281708744 cites W3126776313 @default.
• W4281708744 cites W3128905199 @default.
• W4281708744 cites W3164950287 @default.
• W4281708744 cites W3191734867 @default.
• W4281708744 cites W3198064628 @default.
• W4281708744 cites W3205460942 @default.
• W4281708744 cites W4205515045 @default.
• W4281708744 cites W4210983491 @default.
• W4281708744 cites W4211017340 @default.
• W4281708744 cites W581310418 @default.
• W4281708744 doi "https://doi.org/10.1016/j.arabjc.2022.104018" @default.
• W4281708744 hasPublicationYear "2022" @default.
• W4281708744 type Work @default.
• W4281708744 citedByCount "4" @default.
• W4281708744 countsByYear W42817087442022 @default.
• W4281708744 countsByYear W42817087442023 @default.
• W4281708744 crossrefType "journal-article" @default.
• W4281708744 hasAuthorship W4281708744A5018298015 @default.
• W4281708744 hasAuthorship W4281708744A5035894434 @default.
• W4281708744 hasAuthorship W4281708744A5049096571 @default.
• W4281708744 hasAuthorship W4281708744A5064794022 @default.
• W4281708744 hasAuthorship W4281708744A5089922249 @default.
• W4281708744 hasConcept C105696609 @default.
• W4281708744 hasConcept C121608353 @default.
• W4281708744 hasConcept C126322002 @default.
• W4281708744 hasConcept C153911025 @default.
• W4281708744 hasConcept C185592680 @default.
• W4281708744 hasConcept C190283241 @default.
• W4281708744 hasConcept C202751555 @default.
• W4281708744 hasConcept C2777352226 @default.
• W4281708744 hasConcept C2778004101 @default.
• W4281708744 hasConcept C2780783641 @default.
• W4281708744 hasConcept C2780829032 @default.
• W4281708744 hasConcept C2781401929 @default.
• W4281708744 hasConcept C29537977 @default.
• W4281708744 hasConcept C53227056 @default.
• W4281708744 hasConcept C553184892 @default.
• W4281708744 hasConcept C55493867 @default.
• W4281708744 hasConcept C71924100 @default.
• W4281708744 hasConcept C86803240 @default.
• W4281708744 hasConcept C89138240 @default.
• W4281708744 hasConcept C96232424 @default.

• next